Search

Jun 05, 2025
Advancing and Protecting Medical Liability Reforms
Elizabeth Healy, Vice President, Government and Community Relations, The Doctors Company, Part of TDC Group
TDC Group’s recent medical liability advocacy work has seen success nationwide, with opportunities to enact new reforms in some states, while still facing difficult environments in others.
From The Doctor’s Advocate

October 01, 2024, Healthcare Risk Management
Respond Carefully to Notice of Intent
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, shares suggestions for how to properly respond to patients who communicate their intent to sue.

January 31, 2022, Medscape
Medscape Ob/Gyn Malpractice Report 2021
Peter Kolbert, JD, Senior Vice President of Claim and Litigation Services for Healthcare Risk Advisors, part of TDC Group, notes why ob/gyn carries significant financial exposure with lawsuits.

Aug 27, 2024
Industry and Company News
Announcements in the third quarter 2024 include recognition for our Claims team, a new article by Bob White featured in Fortune, and affirmation of our commitment to health workforce well-being.
From The Doctor’s Advocate

What Do People Actually Want from Primary Care?
Ami Parekh, MD, JD, Chief Health Officer, Included Health, and Member, Board of Governors, The Doctors Company, Part of TDC Group, presents at the 2025 TDC Group Executive Advisory Board Meeting about the current and future state of primary care in the U.S.

Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

Stay in the Know

Sign Up for The Doctor’s Practice

Our monthly e-newsletter features timely articles, videos, and guides on a range of patient safety topics.

Subscribe